532 related articles for article (PubMed ID: 18266746)
1. Development of tolerance to levetiracetam in rats with chronic epilepsy.
van Vliet EA; van Schaik R; Edelbroek PM; da Silva FH; Wadman WJ; Gorter JA
Epilepsia; 2008 Jul; 49(7):1151-9. PubMed ID: 18266746
[TBL] [Abstract][Full Text] [Related]
2. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the multidrug transporter P-glycoprotein improves seizure control in phenytoin-treated chronic epileptic rats.
van Vliet EA; van Schaik R; Edelbroek PM; Redeker S; Aronica E; Wadman WJ; Marchi N; Vezzani A; Gorter JA
Epilepsia; 2006 Apr; 47(4):672-80. PubMed ID: 16650133
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
[TBL] [Abstract][Full Text] [Related]
5. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
Bethmann K; Brandt C; Löscher W
Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
[TBL] [Abstract][Full Text] [Related]
6. Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.
Brandt C; Volk HA; Löscher W
Epilepsia; 2004 Dec; 45(12):1488-97. PubMed ID: 15571506
[TBL] [Abstract][Full Text] [Related]
7. Effects of the novel antiepileptic drug levetiracetam on spontaneous recurrent seizures in the rat pilocarpine model of temporal lobe epilepsy.
Glien M; Brandt C; Potschka H; Löscher W
Epilepsia; 2002 Apr; 43(4):350-7. PubMed ID: 11952764
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus.
Gibbs JE; Walker MC; Cock HR
Epilepsia; 2006 Mar; 47(3):469-78. PubMed ID: 16529608
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
[TBL] [Abstract][Full Text] [Related]
10. Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection.
Ueda Y; Doi T; Nagatomo K; Tokumaru J; Takaki M; Willmore LJ
Brain Res; 2007 Jun; 1151():55-61. PubMed ID: 17408599
[TBL] [Abstract][Full Text] [Related]
11. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
Stefan H; Wang-Tilz Y; Pauli E; Dennhöfer S; Genow A; Kerling F; Lorber B; Fraunberger B; Halboni P; Koebnick C; Gefeller O; Tilz C
Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
[TBL] [Abstract][Full Text] [Related]
12. Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model.
Vinogradova LV; van Rijn CM
Epilepsia; 2008 Jul; 49(7):1160-8. PubMed ID: 18397292
[TBL] [Abstract][Full Text] [Related]
13. Development of tolerance during chronic treatment of kindled rats with the novel antiepileptic drug levetiracetam.
Löscher W; Hönack D
Epilepsia; 2000 Dec; 41(12):1499-506. PubMed ID: 11114206
[TBL] [Abstract][Full Text] [Related]
14. Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy.
Holtman L; van Vliet EA; van Schaik R; Queiroz CM; Aronica E; Gorter JA
Epilepsy Res; 2009 Mar; 84(1):56-66. PubMed ID: 19186029
[TBL] [Abstract][Full Text] [Related]
15. The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy.
Lévesque M; Behr C; Avoli M
Seizure; 2015 Feb; 25():18-25. PubMed ID: 25645630
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiepileptic drugs on spontaneous seizures in epileptic rats.
Nissinen J; Pitkänen A
Epilepsy Res; 2007 Feb; 73(2):181-91. PubMed ID: 17161937
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy.
van Vliet EA; Aronica E; Redeker S; Boer K; Gorter JA
Epilepsia; 2009 Mar; 50(3):422-33. PubMed ID: 18717715
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat.
Chakir A; Fabene PF; Ouazzani R; Bentivoglio M
Brain Res Bull; 2006 Dec; 71(1-3):127-38. PubMed ID: 17113938
[TBL] [Abstract][Full Text] [Related]
19. Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy.
van Vliet EA; Aronica E; Redeker S; Gorter JA
Epilepsia; 2004 Dec; 45(12):1506-16. PubMed ID: 15571508
[TBL] [Abstract][Full Text] [Related]
20. Effects of levetiracetam on hippocampal kindling in Noda epileptic rats.
Ishimaru Y; Chiba S; Serikawa T; Sasa M; Inaba H; Tamura Y; Ishimoto T; Takasaki H; Sakamoto K; Yamaguchi K
Brain Res; 2010 Jan; 1309():104-9. PubMed ID: 19879253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]